Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth B Margulies

Showing results (201-210 of 265) with videos related to

Pageof 27
Sort By:
Cell Metabolism|March 3, 2023
Sustained alternate-day fasting potentiates doxorubicin cardiotoxicityMualla Ozcan, Zhen Guo, Carla Valenzuela Ripoll, et al.
Circulation Research|May 26, 2026
Targeting Arrhythmogenic Late Sodium Current by FHF1<sub>A</sub>-Derivative FixR in Heart Failure CardiomyocytesBence Hegyi, Paweorn Angsutararux, Nourdine Chakouri, et al.
Cell Metabolism|April 23, 2025
Protein O-GlcNAcylation and hexokinase mitochondrial dissociation drive heart failure with preserved ejection fractionYuki Tatekoshi, Amir Mahmoodzadeh, Jason S Shapiro, et al.
JACC. Basic to Translational Science|April 12, 2022
TRAF2, an Innate Immune Sensor, Reciprocally Regulates Mitophagy and Inflammation to Maintain Cardiac Myocyte HomeostasisXiucui Ma, David R Rawnsley, Attila Kovacs, et al.
JAMA Cardiology|July 13, 2017
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical TrialJaved Butler, Kevin J Anstrom, G Michael Felker, et al.
Nature|June 22, 2022
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathyMark Chaffin, Irinna Papangeli, Bridget Simonson, et al.
Journal of the American College of Cardiology|March 21, 2020
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection FractionJulio A Chirinos, Alena Orlenko, Lei Zhao, et al.
Journal of the American Heart Association|March 9, 2018
Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk ScoreEdo Y Birati, Thomas C Hanff, Dawn Maldonado, et al.
JAMA Cardiology|November 3, 2021
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialDouglas L Mann, Michael M Givertz, Justin M Vader, et al.
Circulation|May 15, 2020
Transcriptional and Cellular Diversity of the Human HeartNathan R Tucker, Mark Chaffin, Stephen J Fleming, et al.
Pageof 27

Showing results (201-210 of 265) with videos related to

Sort By:
Pageof 27
Cell Metabolism|March 3, 2023
Sustained alternate-day fasting potentiates doxorubicin cardiotoxicityMualla Ozcan, Zhen Guo, Carla Valenzuela Ripoll, et al.
Circulation Research|May 26, 2026
Targeting Arrhythmogenic Late Sodium Current by FHF1<sub>A</sub>-Derivative FixR in Heart Failure CardiomyocytesBence Hegyi, Paweorn Angsutararux, Nourdine Chakouri, et al.
Cell Metabolism|April 23, 2025
Protein O-GlcNAcylation and hexokinase mitochondrial dissociation drive heart failure with preserved ejection fractionYuki Tatekoshi, Amir Mahmoodzadeh, Jason S Shapiro, et al.
JACC. Basic to Translational Science|April 12, 2022
TRAF2, an Innate Immune Sensor, Reciprocally Regulates Mitophagy and Inflammation to Maintain Cardiac Myocyte HomeostasisXiucui Ma, David R Rawnsley, Attila Kovacs, et al.
JAMA Cardiology|July 13, 2017
Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical TrialJaved Butler, Kevin J Anstrom, G Michael Felker, et al.
Nature|June 22, 2022
Single-nucleus profiling of human dilated and hypertrophic cardiomyopathyMark Chaffin, Irinna Papangeli, Bridget Simonson, et al.
Journal of the American College of Cardiology|March 21, 2020
Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection FractionJulio A Chirinos, Alena Orlenko, Lei Zhao, et al.
Journal of the American Heart Association|March 9, 2018
Predicting Long Term Outcome in Patients Treated With Continuous Flow Left Ventricular Assist Device: The Penn-Columbia Risk ScoreEdo Y Birati, Thomas C Hanff, Dawn Maldonado, et al.
JAMA Cardiology|November 3, 2021
Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical TrialDouglas L Mann, Michael M Givertz, Justin M Vader, et al.
Circulation|May 15, 2020
Transcriptional and Cellular Diversity of the Human HeartNathan R Tucker, Mark Chaffin, Stephen J Fleming, et al.
Pageof 27